US Stock MarketDetailed Quotes
IXHL Incannex Healthcare
- 2.590
- +0.320+14.10%
Close Nov 1 16:00 ET
- 2.727
- +0.137+5.30%
Post 18:57 ET
45.69MMarket Cap-2252P/E (TTM)
2.730High2.200Low141.43KVolume2.330Open2.270Pre Close359.21KTurnover1.05%Turnover RatioLossP/E (Static)17.64MShares12.68052wk High4.07P/B34.79MFloat Cap1.50052wk Low--Dividend TTM13.43MShs Float360.000Historical High--Div YieldTTM23.35%Amplitude1.500Historical Low2.539Avg Price1Lot Size
About Incannex Healthcare Company
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on July 5, 2023 and is headquartered in Norwest, Australia.
Company Profile
SymbolIXHL
Company NameIncannex Healthcare
Listing DateMar 2, 2022
Founded2001
CEOMr. Joel Latham
MarketNASDAQ
Employees9
Fiscal Year Ends06-30
Address8 Century Circuit,Suite 105
CityNorwest
ProvinceNew South Wales (NSW)
CountryAustralia
Zip Code2153
Phone61-4-984-0786
Websitehttp://www.incannex.com
Company Executives
- Name
- Position
- Salary
- Joel Latham
- Director, Chief Executive Officer and President
- 3.03M
- Dr. Luigi M. Barbato
- Chief Medical Officer
- --
- Lekhram Changoer
- Chief Technology Officer
- 157.50K
- Joseph Swan
- Treasurer, Principal Accounting Officer, Chief Financial Officer and Secretary
- --
- Troy Valentine
- Chairman of the Board
- 1.38M
- Dr. George E. Anastassov
- Independent Director
- 175.87K
- Robert Clark
- Independent Director
- 176.09K
- Peter Widdows
- Independent Director
- 316.23K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
